Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript March 19, 2026 Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were ...
As you have seen, it has been a very active time at Eton. During the call, we will review fourth quarter results, provide additional color on the Hemangiol acquisition, and an update on our recent FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results